Clinical trial · Interventional
Hyperimmune Colostrum and Oral Mucositis
The Effect of Hyperimmune Colostrum on Radiation-Induce Oral Mucositis of Patients With Head and Neck Cancer
NCT00699569CI-TRIAL-00001583MucositisunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To study the effect of daily intake of hyperimmune colostrum on prevention and treatment of oral mucositis in patients with head and neck cancer undergoing high-dose radiation.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| hyperimmune colostrum | Dietary Supplement | — | UNRESOLVED |
| Placebo | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- 1
- description
- Patients receiving active investigational product
- interventionNames
- Dietary Supplement: hyperimmune colostrum
- type
- PLACEBO_COMPARATOR
- label
- 2
- description
- Patients receiving Placebo
- interventionNames
- Dietary Supplement: Placebo
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with: naso-pharynx, oral cavity, oro-pharynx and advanced localized laryngeal cancer. Exclusion Criteria: * Other tumors * Non-epithelial tumors * Pregnancy * Poor functional status
References
Publications (0)
Data not yet available
No reference posted for this study.